Page last updated: 2024-09-03

efaproxiral and phosphocreatine

efaproxiral has been researched along with phosphocreatine in 2 studies

Compound Research Comparison

Studies
(efaproxiral)
Trials
(efaproxiral)
Recent Studies (post-2010)
(efaproxiral)
Studies
(phosphocreatine)
Trials
(phosphocreatine)
Recent Studies (post-2010) (phosphocreatine)
7613107,475329575

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Becker, LC; Chacko, VP; DiPaula, AF; Gerstenblith, G; Kass, DA; Mejia, MA; Weiss, RG1
Bottomley, PA; Gerstenblith, G; Najjar, SS; Schulman, SP; Steffen, RP; Waldron, MM; Weiss, RG1

Trials

1 trial(s) available for efaproxiral and phosphocreatine

ArticleYear
Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance, 2005, Volume: 7, Issue:4

    Topics: Adenosine Triphosphate; Aged; Analysis of Variance; Aniline Compounds; Antisickling Agents; Biomarkers; Blood Flow Velocity; Coronary Artery Disease; Coronary Circulation; Cross-Over Studies; Double-Blind Method; Exercise Test; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Oxyhemoglobins; Phosphocreatine; Phosphorus Isotopes; Propionates; Treatment Outcome

2005

Other Studies

1 other study(ies) available for efaproxiral and phosphocreatine

ArticleYear
Preservation of canine myocardial high-energy phosphates during low-flow ischemia with modification of hemoglobin-oxygen affinity.
    The Journal of clinical investigation, 1999, Volume: 103, Issue:5

    Topics: Aniline Compounds; Animals; Antisickling Agents; Dogs; Hemoglobins; Myocardial Ischemia; Oxygen; Oxygen Consumption; Phosphocreatine; Propionates

1999